Delivery Order SPE2DB24D1205-SPE2DB25FCTEN
Award Date
1/21/25
Potential Completion Date
2/11/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is a delivery order for the drug Skyrizi (360 mg/2.4 ml on-body 2.4 ml) and does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,604.63, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a medication, with a performance period ending on March 31, 2025. This contract award is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $56,205.67, is for the delivery of the medication SKYRIZI 150 MG/ML SYRINGEML. This is a firm fixed-price delivery order contract with a completion date of January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $12,236.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialized pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the supply of the specialty medication Skyrizi 360 mg/2.4 ml on-body 2.4 ml. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is a delivery order for the drug Skyrizi 360 mg/2.4 ml on-body 2.4 ml. The contract has an ultimate completion date of December 10, 2024 and was awarded on November 18, 2024. This is not a set-aside contract. AmerisourceBergen, the prime contractor, holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, is for the delivery of the drug Skyrizi (180 mg/1.2 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $11,827.51 and an ultimate completion date of July 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The contract has a firm fixed price of $12,604.63 and a completion date of April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...